Cellkey - About the company
Cellkey is an unfunded company based in Cheongju (South Korea), founded in 2019. It operates as a Provider of AI-driven multiomics data analysis and biomarker discovery solutions. Cellkey has not raised any funding yet. The company has 17 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Araceli Biosciences, ACD and Lodestone Biomedical.
Company Details
Provider of AI-driven multiomics data analysis and biomarker discovery solutions. The company offers services for protein, glycoproteomic, and metabolomic analysis. It develops diagnostic and companion biomarkers through collaborative research with hospitals and pharmaceutical companies. The company provides tools for data management, functional analysis, and glycoprotein analysis.
Key Metrics
Founded Year
2019
Location
Cheongju, South Korea
Stage
Unfunded
Ranked
8th among 17 active competitors
Similar Companies
Sign up to download Cellkey's company profile
Cellkey's funding and investors
Cellkey has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cellkey's Competitors and alternates
Top competitors of Cellkey include Araceli Biosciences, ACD and Lodestone Biomedical. Here is the list of Top 10 competitors of Cellkey, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Araceli Biosciences 2020, United States, Seed | Developer of scientific tools for tissue and cell-based biomarker discovery & drug development | $25.7M | - | 55/100 |
2nd |  ACD 2006, Newark (United States), Acquired | Developer of a transnational research platform for biomarker analysis | $39.4M | 49/100 | |
3rd | Lodestone Biomedical 2015, Hanover (United States), Seed | Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology | $1.18M | 41/100 | |
4th |  HAWK Biosystems 2015, Derio (Spain), Series A | Developer of clinical assays for quantifying novel biomarkers | $3.93M | 37/100 | |
5th | _1566995192677.png?devicePixelRatio=2&height=30&width=30){kind=logo} BioAmp Diagnostics 2017, Berkeley (United States), Seed | Developers of diagnostic tests that help to treat patient with a specific antibiotic | - | 36/100 | |
6th | Developer of bioassays for biopharmaceutical companies and research institutions | $30.5M | 30/100 | ||
7th |  Haga Bio Science Solna (Sweden), Seed | Developer of spatial RNA detection assays for clinical biomarker validation | $2.3M | 28/100 | |
8th | Cellkey 2019, Cheongju (South Korea), Unfunded | Provider of AI-driven multiomics data analysis and biomarker discovery solutions | - | - | 24/100 |
9th | Phoenix Biosystem 2001, Serpentine (Australia), Funding Raised | Developer of biomarker panels and assays for disease assessment and detection | - | 24/100 | |
10th |  ThinkSense 2004, Mclean (United States), Unfunded | A company that provides AI & data-driven digital biomarker technology solutions for clinical trials | - | - | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Cellkey's competitors? Click here to see the top ones
Cellkey's Investments and acquisitions
Cellkey has made no investments or acquisitions yet.
Reports related to Cellkey
Here is the latest report on Cellkey's sector:
Are you a Founder ?
FAQs about Cellkey
Explore our recently published companies
- JNewsy - 2022 founded, Unfunded company
- Content Creation - United Kingdom based, Unfunded company
- Businessforwardai.com - Unfunded company
- lookODU - Kozhikode based, 2019 founded, Seed company
- Iandtech - Johannesburg based, Unfunded company
- Manchester City Football Club - Manchester based, 2013 founded, Unfunded company
